Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on April 30, 2025

Innventure to Present at Upcoming Innovation Conferences
ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV), a technology commercialization platform, today announced that it will sponsor two conferences—the Front End of Innovation 2025 and the IRI Innovators Summit—that explore …

Cell Counting Market to Hit US$16.14 Billion by 2029 with 7.7% CAGR | MarketsandMarkets™.
Delray Beach, FL, April 30, 2025 (GLOBE NEWSWIRE) -- The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion in 2024 and an impressive US$16.14 billion by 2029. …

Turbo Energy Partners with Chilean Utility Saesa to Expand Smart Battery Storage Systems in Latin America
VALENCIA, Spain, April 30, 2025 (GLOBE NEWSWIRE) -- Turbo Energy S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global provider of leading-edge, AI-optimized solar energy storage technologies and solutions, has teamed with Saesa, one of Chile’s …

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
BEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, …

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that is often underdiagnosed or …

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced …

Oncocyte Provides Positive Update on Clinical Trial Progress
Central Institutional Review Board approved, final preparatory steps underway at first transplant centers Three of the top 10 U.S. transplant centers expected to participate in trial Nearly 10% of annual U.S. transplant volume represented in trial site …

Jet.AI and Consensus Core Announce Plans for Multi-Billion Dollar (1.5 GW) AI Data Center Joint Venture in Canada
LAS VEGAS, April 30, 2025 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), a company transitioning to a pure-play artificial-intelligence (“AI”) data-center enterprise, announced the signing of a Letter of Intent (“LOI”) to form …

UAV Corp. Drives Growth with Partnership, Dividend, New Leadership, and DART SA-70 Test Success
WEWAHITCHKA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- UAV Corp. (OTC: UMAV), a leader in UAV and airship technology, announces a strategic partnership with Fifty 1 Labs, Inc. (OTC: FITY), accelerating its mission to advance aerial surveillance and …

SAIC and Bluescape Announce Strategic Partnership to Deliver Secure, Mission-Critical Operations Platform
RESTON, Va., April 30, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) – a mission integrator for delivering advanced technology solutions to the government – announced today that it has established a strategic partnership …

Polyrix Unveils Groundbreaking Inline Metrology System at Control 2025
SAINT-AUGUSTIN, Quebec, April 30, 2025 (GLOBE NEWSWIRE) -- Polyrix, a leader in cutting-edge metrology imaging, proudly announces the launch of the first-ever PolyScan V inline system capable of scanning a full part in 20-seconds, to be debuted at the …

Ocean Power Technologies Ships Multi-Day Capable WAM-V® for Indo-Pacific Operations
MONROE TOWNSHIP, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) ("OPT" or the "Company"), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and …

HII Declares Quarterly Dividend
NEWPORT NEWS, Va., April 30, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.35 per share, payable on June 13, 2025, to shareholders of record as of the close of business on …

Sagtec Global Limited Achieves Strong Fiscal Year 2024 Performance with US$11.6 Million Revenue, Marking 78% Year-over-Year Growth
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable software solutions, today announced its audited financial results for the financial year ended …

Genius Group Announces 2024 Financial Results, 303% NAV Growth
Increase in Net Asset Value (NAV) to $79.4 million from $19.7 million in 2023. SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, …

Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025
LIMERICK, Ireland, April 30, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced today that the Company will release its financial …

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
— Successfully demonstrates strong tolerability, sustained drug release and safety SARASOTA, FL, April 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo,” or the “Company”), a developmental stage biopharmaceutical company focused on …

Cellectar Announces Plan to Explore Strategic Alternatives
FLORHAM PARK, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today …

Xeriant Publishes Video Demonstrating its Nanotech Fire-Retardant Performance
BOCA RATON, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) ("Xeriant" or "the Company"), dedicated to the discovery, development, and commercialization of disruptive technologies in advanced materials and aerospace, publishes a video …

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
CORAL GABLES, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …